From biocontrol to cancer, probiotics and beyond

Colum Dunne

doi:10.4161/bioe.23251

From biocontrol to cancer, probiotics and beyond

Colum Dunne

Research output: Contribution to journal › Article › peer-review

Abstract

This invited commentary covers the period 1997-2012 and has seen changes in terminology that progressed from "basic" and "applied" to "translational" research. In the context of Bioengineered, these changes map readily onto the processes of identifying microbial characteristics appropriate for specific applications, isolation of suitable cultures, strain or genome manipulation and exploitation of these or their metabolomes across a range of settings.

Original language	English
Pages (from-to)	185-190
Number of pages	6
Journal	Bioengineered
Volume	4
Issue number	4
DOIs	https://doi.org/10.4161/bioe.23251
Publication status	Published - Jul 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Biocontrol
Cancer
Industry-led
Medical device
Probiotic
Research strategy

Access to Document

10.4161/bioe.23251

Cite this

@article{ae067e87bcd140d3a4d373c7574d6cd4,

title = "From biocontrol to cancer, probiotics and beyond",

abstract = "This invited commentary covers the period 1997-2012 and has seen changes in terminology that progressed from {"}basic{"} and {"}applied{"} to {"}translational{"} research. In the context of Bioengineered, these changes map readily onto the processes of identifying microbial characteristics appropriate for specific applications, isolation of suitable cultures, strain or genome manipulation and exploitation of these or their metabolomes across a range of settings.",

keywords = "Biocontrol, Cancer, Industry-led, Medical device, Probiotic, Research strategy",

author = "Colum Dunne",

year = "2013",

month = jul,

doi = "10.4161/bioe.23251",

language = "English",

volume = "4",

pages = "185--190",

journal = "Bioengineered",

issn = "1949-1018",

number = "4",

}

TY - JOUR

T1 - From biocontrol to cancer, probiotics and beyond

AU - Dunne, Colum

PY - 2013/7

Y1 - 2013/7

N2 - This invited commentary covers the period 1997-2012 and has seen changes in terminology that progressed from "basic" and "applied" to "translational" research. In the context of Bioengineered, these changes map readily onto the processes of identifying microbial characteristics appropriate for specific applications, isolation of suitable cultures, strain or genome manipulation and exploitation of these or their metabolomes across a range of settings.

AB - This invited commentary covers the period 1997-2012 and has seen changes in terminology that progressed from "basic" and "applied" to "translational" research. In the context of Bioengineered, these changes map readily onto the processes of identifying microbial characteristics appropriate for specific applications, isolation of suitable cultures, strain or genome manipulation and exploitation of these or their metabolomes across a range of settings.

KW - Biocontrol

KW - Cancer

KW - Industry-led

KW - Medical device

KW - Probiotic

KW - Research strategy

UR - https://www.scopus.com/pages/publications/84883243137

U2 - 10.4161/bioe.23251

DO - 10.4161/bioe.23251

M3 - Article

C2 - 23247300

AN - SCOPUS:84883243137

SN - 1949-1018

VL - 4

SP - 185

EP - 190

JO - Bioengineered

JF - Bioengineered

IS - 4

ER -

From biocontrol to cancer, probiotics and beyond

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this